Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Haemolytic anaemia
ADR ID BADD_A01933
ADR Hierarchy
01      Blood and lymphatic system disorders
01.06      Haemolyses and related conditions
01.06.03      Anaemias haemolytic NEC
01.06.03.002      Haemolytic anaemia
Description A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES). | Acquired anemia due to destruction of red blood cells by physical trauma such as FIBRIN strands in the blood vessels, artificial heart valve, AORTIC COARCTATION. I can also be associated with hematologic diseases such as DISSEMINATED INTRAVASCULAR COAGULATION; HEMOLYTIC-UREMIC SYNDROME; and THROMBOTIC THROMBOCYTOPENIC PURPURA. [MeSH]
MedDRA Code 10018916
MeSH ID D000743
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Acquired haemolytic anaemia | Acquired haemolytic anaemia, unspecified | Acquired haemolytic anaemias | Acquired hemolytic anemia, unspecified | Acquired hemolytic anemias | Anaemia haemolytic | Anaemia primaquine sensitivity | Anemia hemolytic (NOS) | Anemia hemolytic occult | Anemia primaquine sensitivity type | Haemolytic anaemia | Haemolytic anaemia acquired | Haemolytic anaemia drug-induced | Haemolytic anaemia NOS | Hemolytic anemia | Hemolytic anemia (NOS) | Hemolytic anemia with antidrug antibody | Non-autoimmune haemolytic anaemia | Non-autoimmune haemolytic anaemias | Non-autoimmune hemolytic anemia, unspecified | Non-autoimmune hemolytic anemias | Other non-autoimmune hemolytic anemias | Primaquine sensitivity anaemia | Primaquine sensitivity anemia | Acquired hemolytic anemia | Anemia hemolytic | Hemolytic anemia acquired | Hemolytic anemia drug-induced | Non-autoimmune hemolytic anemia | Anaemia haemolytic occult | Haemolytic anaemia with antidrug antibody | Non-autoimmune haemolytic anaemia, unspecified | Anaemia primaquine sensitivity type | Acute hemolytic anemia | Acute haemolytic anaemia | Anemia, Hemolytic | Hemolytic Anemia | Microangiopathic Hemolytic Anemia | Anemia, Hemolytic, Acquired | Hemolytic Anemia, Acquired | Acquired Hemolytic Anemia | Anemia, Acquired Hemolytic | Anemia, Microangiopathic | Microangiopathic Anemia
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01423Methyclothiazide--
BADD_D01425Methyldopa0.001540%
BADD_D01426Methyldopate hydrochloride--
BADD_D01427Methylene blue cation--
BADD_D01433Methylprednisolone0.000080%
BADD_D01455Micafungin--
BADD_D01470Minocycline0.000413%
BADD_D01471Minocycline anion--
BADD_D01472Minocycline hydrochloride--
BADD_D01478Mitomycin--
BADD_D01485Moexipril hydrochloride--
BADD_D01486Moexiprilat--
BADD_D01496Montelukast0.000022%
BADD_D01507Mycophenolate mofetil--
BADD_D01521Nalidixic acid--
BADD_D01533Naproxen--
BADD_D01534Naproxen sodium--
BADD_D01566Nifedipine--
BADD_D01567Nilotinib0.000336%
BADD_D01576Nitrofurantoin--
BADD_D01577Nitrofurantoin (macrocrystals)--
BADD_D01578Nitrofurantoin (monohydrate/macrocrystals)--
BADD_D01587Norfloxacin--
BADD_D01601Olaparib0.000470%
BADD_D01602Olmesartan--
BADD_D01607Olsalazine--
BADD_D01608Olsalazine sodium--
BADD_D01614Omeprazole--
BADD_D01615Omeprazole magnesium--
BADD_D01617Ondansetron0.000043%
The 8th Page    First    Pre   8 9 10 11 12    Next   Last    Total 13 Pages
ADReCS-Target
ADR Term Drug Name Target